The comparison between Efficacy of Treatment With Propranolol in Newborns With Retinopathy of Prematurity and control
Phase 2
- Conditions
- Retinopathy of prematurity.Retinopathy of prematurity
- Registration Number
- IRCT2015102524681N1
- Lead Sponsor
- Vice chancellor for research, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Children with the diagnosis of retinopathy prematurity and lack of diseases such as any type of heart disease; low blood pressure; brain hemmorhage included in this study. Patients with severe complications of propranolol such as severe bradycardy or low blood pressure excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grade of retinopathy. Timepoint: Each 2 weeks upto complete vascularization. Method of measurement: Grade of retinopathy 1-5.
- Secondary Outcome Measures
Name Time Method